Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Gynecology

  Free Subscription


21.10.2019

1 Acta Obstet Gynecol Scand
1 Am J Obstet Gynecol
2 Aust N Z J Obstet Gynaecol
2 BMC Cancer
1 BMJ
1 Cancer
1 Cancer Lett
2 Cancer Res
1 Eur J Obstet Gynecol Reprod Biol
5 Fertil Steril
2 Gynecol Endocrinol
21 Gynecol Oncol
1 Hum Reprod
2 Int J Cancer
2 Int J Gynaecol Obstet
3 J Clin Endocrinol Metab
1 JAMA
1 Lancet
3 Lancet Diabetes Endocrinol
2 Lancet Glob Health
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. VISTAD I
    Electronic patient-reported outcomes to monitor symptoms after gynecological cancer treatment.
    Acta Obstet Gynecol Scand. 2019;98:1365-1366.
    PubMed     Text format    


    Am J Obstet Gynecol

  2. MARLATT KL, Redman LM, Beyl RA, Smith SR, et al
    Racial differences in body composition and cardiometabolic risk during the menopause transition: a prospective, observational cohort study.
    Am J Obstet Gynecol. 2019 Oct 11. pii: S0002-9378(19)31218.
    PubMed     Text format     Abstract available


    Aust N Z J Obstet Gynaecol


  3. Annual Scientific Meeting of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) - Stop. Start. Continue., Melbourne Convention Centre, Melbourne, Victoria, 13 - 16 October 2019.
    Aust N Z J Obstet Gynaecol. 2019;59 Suppl 1:3-116.
    PubMed     Text format    

  4. STEELE E, Bush D, Healey M, Rapsey CM, et al
    Investigating the care needs of those with endometriosis: Are we listening to the patients?
    Aust N Z J Obstet Gynaecol. 2019 Oct 16. doi: 10.1111/ajo.13080.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. LOGHMANI L, Saedi N, Omani-Samani R, Safiri S, et al
    Tubal ligation and endometrial Cancer risk: a global systematic review and meta-analysis.
    BMC Cancer. 2019;19:942.
    PubMed     Text format     Abstract available

  6. CHAN KK, Wong ES, Wong IT, Cheung CL, et al
    Overexpression of iASPP is required for autophagy in response to oxidative stress in choriocarcinoma.
    BMC Cancer. 2019;19:953.
    PubMed     Text format     Abstract available


    BMJ

  7. HENRICHS J, Verfaille V, Jellema P, Viester L, et al
    Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre, stepped wedge cluster randomised trial.
    BMJ. 2019;367:l5517.
    PubMed     Text format     Abstract available


    Cancer

  8. PRINTZ C
    Survey of US gynecologic oncologists finds that approximately 64% have experienced sexual harassment.
    Cancer. 2019;125:3691.
    PubMed     Text format    


    Cancer Lett

  9. ASANTE DB, Calapre L, Ziman M, Meniawy TM, et al
    Liquid biopsy in Ovarian cancer using Circulating Tumor DNA and Cells: Ready for Prime Time?
    Cancer Lett. 2019 Oct 11. pii: S0304-3835(19)30511.
    PubMed     Text format     Abstract available


    Cancer Res

  10. KANAKKANTHARA A, Kurmi K, Ekstrom TL, Hou X, et al
    BRCA1 Deficiency Upregulates NNMT Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents.
    Cancer Res. 2019 Oct 16. pii: 0008-5472.CAN-19-1405.
    PubMed     Text format     Abstract available

  11. CARBONE M, Melino G
    Stearoyl CoA Desaturase Regulates Ferroptosis in Ovarian Cancer Offering New Therapeutic Perspectives.
    Cancer Res. 2019;79:5149-5150.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  12. BACHKANGI P, Taylor AH, Bari M, Maccarrone M, et al
    Prediction of preterm labour from a single blood test: The role of the endocannabinoid system in predicting preterm birth in high-risk women.
    Eur J Obstet Gynecol Reprod Biol. 2019;243:1-6.
    PubMed     Text format     Abstract available


    Fertil Steril

  13. OKTAY K, Bedoschi G
    Fertility preservation in girls with Turner syndrome: limitations, current success and future prospects.
    Fertil Steril. 2019;111:1124-1126.
    PubMed     Text format    

  14. CHEN LM, Blank SV, Burton E, Glass K, et al
    Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review.
    Fertil Steril. 2019 Oct 3. pii: S0015-0282(19)31982.
    PubMed     Text format     Abstract available

  15. FLYCKT RL
    Setting the focus on patient selection for minimally invasive myomectomy: operating times and surgical morbidity in a large database study.
    Fertil Steril. 2019;111:1127-1128.
    PubMed     Text format    

  16. SMITH MB
    Mind the gap! Addressing gender wage inequality within reproductive endocrinology and infertility.
    Fertil Steril. 2019;111:1121.
    PubMed     Text format    

  17. MUMFORD SL, Hotaling JM
    Should all men being evaluated for couple infertility have an endocrine and reproductive urology evaluation?
    Fertil Steril. 2019;111:1107-1108.
    PubMed     Text format    


    Gynecol Endocrinol

  18. DOTLIC J, Nicevic S, Kurtagic I, Radovanovic S, et al
    Hormonal therapy in menopausal transition: implications for improvement of health-related quality of life.
    Gynecol Endocrinol. 2019 Oct 11:1-6. doi: 10.1080/09513590.2019.1676409.
    PubMed     Text format     Abstract available

  19. MARIAN S, Hermanowicz-Szamatowicz K
    Endometriosis - a decade later - still an enigmatic disease. What is the new in the diagnosis and treatment?
    Gynecol Endocrinol. 2019 Oct 12:1-5. doi: 10.1080/09513590.2019.1675045.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  20. CHEN LM, Blank SV, Burton E, Glass K, et al
    Reproductive and Hormonal Considerations in Women at Increased Risk for Hereditary Gynecologic Cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review.
    Gynecol Oncol. 2019 Aug 22. pii: S0090-8258(19)31333.
    PubMed     Text format     Abstract available

  21. VAN KOL KGG, Vergeldt TFM, Bekkers RLM
    Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates.
    Gynecol Oncol. 2019 Oct 9. pii: S0090-8258(19)31546.
    PubMed     Text format     Abstract available

  22. MULTINU F, Ducie JA, Eriksson AGZ, Schlappe BA, et al
    Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm.
    Gynecol Oncol. 2019 Oct 8. pii: S0090-8258(19)31531.
    PubMed     Text format     Abstract available

  23. MARCHETTI C, Rosati A, Scaletta G, Pietragalla A, et al
    Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer before olaparib maintenance: Still getting any benefit? A case-control study.
    Gynecol Oncol. 2019 Oct 9. pii: S0090-8258(19)31545.
    PubMed     Text format     Abstract available

  24. KURODA T, Ogiwara H, Sasaki M, Takahashi K, et al
    Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma.
    Gynecol Oncol. 2019 Oct 8. pii: S0090-8258(19)31559.
    PubMed     Text format     Abstract available

  25. LABIDI-GALY SI, de La Motte Rouge T, Derbel O, Wolfer A, et al
    Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers.
    Gynecol Oncol. 2019 Oct 8. pii: S0090-8258(19)31528.
    PubMed     Text format     Abstract available

  26. BERG T, Nottrup TJ, Roed H
    Gemcitabine for recurrent ovarian cancer - a systematic review and meta-analysis.
    Gynecol Oncol. 2019 Oct 8. pii: S0090-8258(19)31547.
    PubMed     Text format     Abstract available

  27. RAKOWSKI JA, Holloway RW, Ahmad S, Jeppson CN, et al
    A prospective randomized trial of intravenous ketorolac vs. acetaminophen administered with opioid patient-controlled analgesia in gynecologic surgery.
    Gynecol Oncol. 2019 Oct 7. pii: S0090-8258(19)31543.
    PubMed     Text format     Abstract available

  28. ELIAS KM, Berkowitz RS, Horowitz NS
    Continued hCG surveillance following chemotherapy for gestational trophoblastic neoplasia: When is enough enough?
    Gynecol Oncol. 2019;155:1-2.
    PubMed     Text format    

  29. TAYLAN E, Oktay K
    Fertility preservation in gynecologic cancers.
    Gynecol Oncol. 2019 Oct 8. pii: S0090-8258(19)31532.
    PubMed     Text format     Abstract available

  30. NOMURA H, Aoki D, Susumu N, Mizuno M, et al
    Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial.
    Gynecol Oncol. 2019 Oct 7. pii: S0090-8258(19)31544.
    PubMed     Text format     Abstract available

  31. BAIOCCHI G, Salani R
    Meeting report from the 19th meeting of the International Gynecologic Cancer Society (IGCS) 2019: Summary of selected abstracts and meeting highlights.
    Gynecol Oncol. 2019 Oct 10. pii: S0090-8258(19)31563.
    PubMed     Text format    

  32. TATEBE K, Hasan Y, Son CH
    Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: Outcomes by risk factors.
    Gynecol Oncol. 2019 Oct 11. pii: S0090-8258(19)31541.
    PubMed     Text format     Abstract available

  33. TE GROOTENHUIS NC, Pouwer AW, de Bock GH, Hollema H, et al
    Margin status revisited in vulvar squamous cell carcinoma.
    Gynecol Oncol. 2019;154:266-275.
    PubMed     Text format     Abstract available

  34. SALYER C, Kobelka C, Barrie A, Weintraub MR, et al
    Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations.
    Gynecol Oncol. 2019;154:374-378.
    PubMed     Text format     Abstract available

  35. WRIGHT TC JR, Stoler MH, Parvu V, Yanson K, et al
    Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, >/=21years of age, with ASC-US or LSIL cytology.
    Gynecol Oncol. 2019 May 31. pii: S0090-8258(19)31256.
    PubMed     Text format     Abstract available

  36. BEDELL SM, Hedberg C, Griffin A, Pearson H, et al
    Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins.
    Gynecol Oncol. 2019;154:276-279.
    PubMed     Text format     Abstract available

  37. ARO K, Nieminen P, Louvanto K, Jakobsson M, et al
    Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women.
    Gynecol Oncol. 2019 Jun 5. pii: S0090-8258(19)31268.
    PubMed     Text format     Abstract available

  38. DICK S, Kremer WW, De Strooper LMA, Lissenberg-Witte BI, et al
    Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis.
    Gynecol Oncol. 2019 Jun 7. pii: S0090-8258(19)31279.
    PubMed     Text format     Abstract available

  39. LI W, Meng Y, Wang Y, Cheng X, et al
    Association of age and viral factors with high-risk HPV persistence: A retrospective follow-up study.
    Gynecol Oncol. 2019 Jun 24. pii: S0090-8258(19)31270.
    PubMed     Text format     Abstract available

  40. DUDLEY S, Viswanathan A
    Margins in vulvar cancer: challenges to classical clinicopathologic vulvar recurrence risk factors.
    Gynecol Oncol. 2019;154:253-254.
    PubMed     Text format    


    Hum Reprod

  41. SUDA K, Nakaoka H, Yoshihara K, Ishiguro T, et al
    Different mutation profiles between epithelium and stroma in endometriosis and normal endometrium.
    Hum Reprod. 2019 Oct 17. pii: 5588672. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Cancer

  42. LEE YJ, Kim D, Shim JE, Bae SJ, et al
    Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy.
    Int J Cancer. 2019 Oct 11. doi: 10.1002/ijc.32729.
    PubMed     Text format     Abstract available

  43. FELIX AS, McLaughlin EM, Caan BJ, Cohn DE, et al
    Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.
    Int J Cancer. 2019 Oct 16. doi: 10.1002/ijc.32740.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  44. HISANO M, Mitsui M, Sago H, Yamaguchi K, et al
    Thromboprophylaxis with antithrombin gamma and unfractionated heparin for a pregnant woman complicated by hereditary antithrombin deficiency.
    Int J Gynaecol Obstet. 2019 Oct 12. doi: 10.1002/ijgo.12996.
    PubMed     Text format     Abstract available

  45. VERMA S, Bakshi D, Sharma V, Sharma I, et al
    Genetic variants of DNAH11 and LRFN2 genes and their association with ovarian and breast cancer.
    Int J Gynaecol Obstet. 2019 Oct 12. doi: 10.1002/ijgo.12997.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  46. WIWATPANIT T, Murphy AR, Lu Z, Urbanek M, et al
    Scaffold-free endometrial organoids respond to excess androgens associated with polycystic ovarian syndrome.
    J Clin Endocrinol Metab. 2019 Oct 16. pii: 5588091. doi: 10.1210.
    PubMed     Text format     Abstract available

  47. GREENDALE GA, Huang M, Cauley JA, Liao D, et al
    Trabecular Bone Score Declines During the Menopause Transition: the Study of Women's Health Across the Nation (SWAN).
    J Clin Endocrinol Metab. 2019 Oct 15. pii: 5588030. doi: 10.1210.
    PubMed     Text format     Abstract available

  48. CLEEMANN L, Holm K, Fallentin E, Moller N, et al
    Effect of dosage of 17ss-estradiol on uterine growth in Turner syndrome - a randomized controlled clinical pilot trial.
    J Clin Endocrinol Metab. 2019 Oct 15. pii: 5587948. doi: 10.1210.
    PubMed     Text format     Abstract available


    JAMA

  49. ENSRUD KE, Crandall CJ
    Bisphosphonates for Postmenopausal Osteoporosis.
    JAMA. 2019 Oct 17. pii: 2753530. doi: 10.1001/jama.2019.15781.
    PubMed     Text format    


    Lancet

  50. O'NEILL D
    Abortion as a moral good?
    Lancet. 2019;394:1323-1324.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  51. LIU B, Bao W
    Maternal pre-pregnancy obesity and preterm birth: more explorations needed - Authors' reply.
    Lancet Diabetes Endocrinol. 2019;7:829-830.
    PubMed     Text format    

  52. DAVIS SR
    Menopausal hormone therapy: is there cause for concern?
    Lancet Diabetes Endocrinol. 2019;7:825-827.
    PubMed     Text format    

  53. YUAN Y, Niu W
    Maternal pre-pregnancy obesity and preterm birth: more explorations needed.
    Lancet Diabetes Endocrinol. 2019;7:829.
    PubMed     Text format    


    Lancet Glob Health

  54. LEWKOWITZ AK, Tuuli MG
    Iron-deficiency anaemia in pregnancy: the role of hepcidin.
    Lancet Glob Health. 2019;7:e1476-e1477.
    PubMed     Text format    

  55. BAH A, Muhammad AK, Wegmuller R, Verhoef H, et al
    Hepcidin-guided screen-and-treat interventions against iron-deficiency anaemia in pregnancy: a randomised controlled trial in The Gambia.
    Lancet Glob Health. 2019;7:e1564-e1574.
    PubMed     Text format     Abstract available


    PLoS One

  56. CARLOS S, Lopez-Del Burgo C, Ndarabu A, Osorio A, et al
    Heterosexual oral and anal sex in Kinshasa (D.R.Congo): Data from OKAPI prospective cohort.
    PLoS One. 2019;14:e0210398.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: